BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 73850)

  • 1. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
    Reynolds F; Ziroyanis PN; Jones NF; Smith SE
    Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin and IgA concentrations in plasma and saliva in epileptic children.
    Modéer T; Tomson G; Falk O; Rane A
    Acta Paediatr Scand; 1981; 70(3):373-8. PubMed ID: 7246128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin kinetics during pregnancy and the puerperium.
    Knott C; Williams CP; Reynolds F
    Br J Obstet Gynaecol; 1986 Oct; 93(10):1030-7. PubMed ID: 3790462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.
    Cook CE; Amerson E; Poole WK; Lesser P; O'Tuama L
    Clin Pharmacol Ther; 1975 Dec; 18(6):742-7. PubMed ID: 1204279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary phenytoin levels in institutionalized epileptics.
    Hassell T; O'Donnell J; Pearlman J; Tesini D; Best H; Murphy T
    J Chronic Dis; 1983; 36(12):899-906. PubMed ID: 6655035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum and salivary phenytoin concentrations in Thai epileptic children.
    Liamsuwan S; Jaiweerawattana U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S172-7. PubMed ID: 22043772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of phenytoin determinations in plasma, plasma dialysate and saliva for control of antiepileptic therapy in children.
    Brügmann G; Kleinau E; Nolte R; Petruch F
    Klin Wochenschr; 1979 Jan; 57(2):93-4. PubMed ID: 762949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin therapy for epileptic children: evaluation of salivary and plasma concentrations and of methods of assessing compliance.
    Zysset T; Rüdeberg A; Vassella F; Küpfer A; Bircher J
    Dev Med Child Neurol; 1981 Feb; 23(1):66-75. PubMed ID: 6781961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free phenytoin monitoring in serum and saliva of epileptic patients in China.
    Cai WM; Zhu GZ; Chen G
    Ther Drug Monit; 1993 Feb; 15(1):31-4. PubMed ID: 8451777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.
    Krasowski MD; Penrod LE
    BMC Med Inform Decis Mak; 2012 Feb; 12():7. PubMed ID: 22333264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples.
    Mucklow JC; Bacon CJ; Hierons AM; Webb JK; Rawlins MD
    Ther Drug Monit; 1981; 3(3):275-7. PubMed ID: 7324092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW
    Clin Pharmacol Ther; 1980 Feb; 27(2):170-8. PubMed ID: 7353335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous valproate: effects on plasma and saliva phenytoin levels.
    Pisani FD; Di Perri RG
    Neurology; 1981 Apr; 31(4):467-70. PubMed ID: 6783979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.
    Paxton JW; Rowell F; Ratcliffe JG; Lambie DG; Nanda R; Melville ID; Johnson RH
    Eur J Clin Pharmacol; 1977; 11(1):71-4. PubMed ID: 832662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.